(Q46788021)

25 December 2017

title

Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients (English)

1 reference

25 December 2017

0 references

Alves-Leon SV

1

1 reference

25 December 2017

Papais-Alvarenga R

2

1 reference

25 December 2017

Magalhães M

3

1 reference

25 December 2017

Alvarenga M

4

1 reference

25 December 2017

Thuler LC

5

1 reference

25 December 2017

Fernández y Fernandez O

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

25 December 2017

Acta Neurologica Scandinavica

published in

1 reference

25 December 2017

volume

115

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

306-311

1 reference

25 December 2017

Determination of soluble ICAM-1 and TNFalphaR in the cerebrospinal fluid and serum levels in a population of Brazilian patients with relapsing-remitting multiple sclerosis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

A meta-analysis of whole genome linkage screens in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

Response to interferon beta-1a treatment in African American multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

Genetics of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

Genomics and proteomics: role in the management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

Moving towards individualized medicine with pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

HLA class II and response to interferon-beta in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

Pharmacogenetic Development of Personalized Medicine: Multiple Sclerosis Treatment as a Model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00750.X

10.1111/J.1600-0404.2006.00750.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

release_6oxsgp5hdnbwjnlmtxaysayxem

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6oxsgp5hdnbwjnlmtxaysayxem

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

25 December 2017